NCT06395675View on ClinicalTrials.gov

Clinical Evaluation of the ID NOW™ CT/NG Test

NANot yet recruitingINTERVENTIONAL

Enrollment

7,100

Participants

Timeline

Start Date

July 9, 2024

Primary Completion Date

January 9, 2025

Study Completion Date

January 9, 2025

Conditions

Chlamydia Trachomatis InfectionNeisseria Gonorrheae InfectionAsymptomatic Condition

Interventions

DIAGNOSTIC_TEST

ID NOW™

"The ID NOW™ CT/NG is an in vitro qualitative molecular assay for the rapid differential.~detection of Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) in urine, and self-collected vaginal swabs (SVS) in symptomatic and asymptomatic individuals."

Trial Locations (1)

70119

LSU Crescent Care Sexual Health Clinic, New Orleans

All Listed Sponsors

lead

Abbott Rapid Dx

INDUSTRY

NCT06395675 - Clinical Evaluation of the ID NOW™ CT/NG Test | Biotech Hunter | Biotech Hunter